Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer

Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer

Intravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself.

Bibliographic Details
Main Authors: Luis Felipe Lara Moscoloni, Maximiliano Santarelli, Juan Spagnuolo
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Urology Case Reports
Subjects:
Bacillus Calmette-Guérin
Tuberculous epididymo-orchitis
Non-muscular invasive
Bladder cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442021000693
id doaj-1be25cc1fa084772a7971811a1f464b1
record_format Article
spelling doaj-1be25cc1fa084772a7971811a1f464b12021-05-26T04:27:03ZengElsevierUrology Case Reports2214-44202021-07-0137101629Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancerLuis Felipe Lara Moscoloni0Maximiliano Santarelli1Juan Spagnuolo2Corresponding author.; Hospital Complejo Medico Churruca – Visca, Buenos Aires, ArgentinaHospital Complejo Medico Churruca – Visca, Buenos Aires, ArgentinaHospital Complejo Medico Churruca – Visca, Buenos Aires, ArgentinaIntravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself.http://www.sciencedirect.com/science/article/pii/S2214442021000693Bacillus Calmette-GuérinTuberculous epididymo-orchitisNon-muscular invasiveBladder cancer
collection DOAJ
language English
format Article
sources DOAJ
author Luis Felipe Lara Moscoloni
Maximiliano Santarelli
Juan Spagnuolo
spellingShingle Luis Felipe Lara Moscoloni
Maximiliano Santarelli
Juan Spagnuolo
Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
Urology Case Reports
Bacillus Calmette-Guérin
Tuberculous epididymo-orchitis
Non-muscular invasive
Bladder cancer
author_facet Luis Felipe Lara Moscoloni
Maximiliano Santarelli
Juan Spagnuolo
author_sort Luis Felipe Lara Moscoloni
title Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_short Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_full Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_fullStr Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_full_unstemmed Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_sort tuberculous epididymo-orchitis secondary to bacillus calmette-guérin (bcg) in non-muscular invasive bladder cancer
publisher Elsevier
series Urology Case Reports
issn 2214-4420
publishDate 2021-07-01
description Intravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself.
topic Bacillus Calmette-Guérin
Tuberculous epididymo-orchitis
Non-muscular invasive
Bladder cancer
url http://www.sciencedirect.com/science/article/pii/S2214442021000693
work_keys_str_mv AT luisfelipelaramoscoloni tuberculousepididymoorchitissecondarytobacilluscalmetteguerinbcginnonmuscularinvasivebladdercancer
AT maximilianosantarelli tuberculousepididymoorchitissecondarytobacilluscalmetteguerinbcginnonmuscularinvasivebladdercancer
AT juanspagnuolo tuberculousepididymoorchitissecondarytobacilluscalmetteguerinbcginnonmuscularinvasivebladdercancer
_version_ 1721426591703105536

Similar Items